Can you take pregabalin and gabapentin (GABA analogs) together?

From the Guidelines

Taking pregabalin and gabapentin together is generally not recommended due to the potential for increased side effects and limited additional therapeutic benefit. These medications are both GABA analogs that work through similar mechanisms in the body, primarily by binding to calcium channels in the nervous system to reduce the release of excitatory neurotransmitters 1. Using them simultaneously provides little additional therapeutic benefit while potentially increasing the risk of side effects such as dizziness, drowsiness, confusion, and respiratory depression.

Key Considerations

• Healthcare providers typically prescribe either pregabalin or gabapentin, not both concurrently, as seen in studies on neuropathic pain management 1.
• If one medication is not effective at an optimal dose, physicians usually switch completely to the other rather than combining them.
• In cases where a patient is being transitioned from one medication to the other, there may be a brief overlap period during which doses are carefully adjusted under medical supervision.
• Anyone currently taking either medication should consult their healthcare provider before making any changes to their treatment regimen, as abrupt discontinuation can cause withdrawal symptoms including insomnia, nausea, headache, and in rare cases, seizures.

Dosage and Administration

• The starting dose and titration schedule for gabapentin and pregabalin are well-established, with gabapentin starting at 100-300 mg nightly and pregabalin starting at 50 mg 3 times a day 1.
• Dose adjustments are required for patients with renal insufficiency, and slower titration is recommended for the elderly or medically frail.

Clinical Evidence

• Studies have shown that combination therapies may have a role in the treatment of neuropathic pain, but the combination of pregabalin and gabapentin is not specifically recommended due to their similar mechanisms of action 1.
• Other anticonvulsant agents may be considered for patients with neuropathic pain, and the choice of medication should be individualized based on patient factors and response to treatment.

From the FDA Drug Label

The pharmacokinetic interactions of pregabalin and gabapentin were investigated in 12 healthy subjects following concomitant single-dose administration of 100-mg pregabalin and 300-mg gabapentin and in 18 healthy subjects following concomitant multiple-dose administration of 200-mg pregabalin every 8 hours and 400-mg gabapentin every 8 hours Gabapentin pharmacokinetics following single- and multiple-dose administration were unaltered by pregabalin coadministration. The extent of pregabalin absorption was unaffected by gabapentin coadministration, although there was a small reduction in rate of absorption

Key Points:

• Pregabalin and gabapentin can be taken together.
• Gabapentin pharmacokinetics are not altered by pregabalin coadministration.
• Pregabalin absorption is not significantly affected by gabapentin coadministration.

2

From the Research

Combination Therapy with Gabapentin and Pregabalin

• The combination of gabapentin and pregabalin has been used in both clinical and research situations to treat neuropathic pain conditions, with some studies suggesting a synergistic effect in pain control without significant pharmacokinetic interactions 3.
• However, there are also reports of adverse effects, such as drowsiness, dizziness, fatigue, and ataxia, when these medications are used together 4.
• The use of gabapentin and pregabalin in combination may require careful consideration of pharmacokinetics, drug interactions, and adverse reactions to ensure safe and effective treatment 3.

Efficacy and Safety of Gabapentin and Pregabalin

• A systematic review and meta-analysis found that pregabalin demonstrated superior efficacy in alleviating neuropathic pain compared to gabapentin, with improved patient-reported outcomes and lower opioid consumption 5.
• Gabapentin had a higher incidence of nausea and vomiting compared to pregabalin 5.
• Both gabapentin and pregabalin have been associated with serious breathing problems, such as respiratory depression, particularly when used in combination with other respiratory depressants like opioids 6.

Clinical Considerations

• The decision to use gabapentin and pregabalin in combination should be made on a case-by-case basis, taking into account the individual patient's needs and medical history 3.
• Healthcare providers should carefully monitor patients for adverse effects and adjust treatment regimens as needed to minimize risks and optimize benefits 4.
• Education and awareness of potential adverse effects can help patients detect and report problems early, ensuring timely intervention and improved outcomes 6.